Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer

JOURNAL ARTICLE published 29 February 2020 in BioScience Trends

Authors: Mila P. Petrova | Mariyana I. Eneva | Jeliazko I. Arabadjiev | Nikolay V. Conev | Eleonora G. Dimitrova | Krassimir D. Koynov | Teodora S. Karanikolova | Spartak S. Valev | Radostina B. Gencheva | Georgi A. Zhbantov | Anika I. Ivanova | Iva I. Sarbianova | Constanta V. Timcheva | Ivan S. Donev